Antibody response to a third booster dose of SARS-CoV-2 vaccination in adults with haematological and solid cancer: a systematic reviewArticle Published on 2022-11-012022-11-15 Journal: British Journal of Cancer [Category] [DOI] 10.1038/s41416-022-01951-y PMC 바로가기
Quantitative Analysis of SARS-CoV-2 Antibody Levels in Cancer Patients Post Three Doses of Immunization and Prior to Breakthrough COVID-19 InfectionsArticle Published on 2022-09-282022-11-15 Journal: Current Oncology [Category] [DOI] 10.3390/curroncol29100554 PMC 바로가기
Survival and late effects of hematopoietic cell transplantation in patients with thalassemia major Research Published on 2022-08-242022-10-05 Journal: Bone marrow transplantation [Category] [DOI] 10.1038/s41409-022-01786-4 [Article Type] Research
Breakthrough COVID-19 Infection During the Delta Variant Dominant Period: Individualized Care Based on Vaccination Status Is NeededArticle Published on 2022-08-152022-11-16 Journal: Journal of Korean medical science [Category] [DOI] 10.3346/jkms.2022.37.e252 PMC 바로가기
Solid cancer patients achieve adequate immunogenicity and low rate of severe adverse events after SARS-CoV-2 vaccination고형암 환자는 SARS-CoV-2 백신 접종 후 적절한 면역원성과 낮은 중증 부작용 발생률 달성Article Published on 2022-07-012022-09-11 Journal: Future Oncology [Category] [DOI] 10.2217/fon-2022-0148 PMC 바로가기 [Article Type] Article
Incidence and immunomic features of apyretic COVID-19 in patients affected by solid tumors: a prospective cohort study고형 종양의 영향을 받는 환자에서 발열성 COVID-19의 발병률 및 면역학적 특징: 전향적 코호트 연구Article Published on 2022-05-142022-09-11 Journal: Journal of Translational Medicine [Category] [DOI] 10.1186/s12967-022-03429-0 PMC 바로가기 [Article Type] Article
Enhanced SARS-CoV-2 breakthrough infections in patients with hematologic and solid cancers due to OmicronOmicron으로 인한 혈액암 및 고형암 환자의 SARS-CoV-2 돌발성 감염 강화Article Published on 2022-05-092022-09-12 Journal: Cancer cell [Category] [DOI] 10.1016/j.ccell.2022.04.003 PMC 바로가기 [Article Type] Article
Immunogenicity and safety after the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors on active treatment: a prospective cohort study활성 치료 중인 고형 종양 환자에서 BNT162b2 항-SARS-CoV-2 백신 3차 접종 후 면역원성과 안전성: 전향적 코호트 연구Article Published on 2022-04-012022-09-11 Journal: ESMO open [Category] [DOI] 10.1016/j.esmoop.2022.100458 PMC 바로가기 [Article Type] Article
Safety and immunogenicity of the COVID-19 vaccine BNT162b2 in patients undergoing chemotherapy for solid cancer고형암으로 항암화학요법을 받는 환자에서 코로나19 백신 BNT162b2의 안전성과 면역원성Article Published on 2022-04-012022-09-12 Journal: Journal of infection and chemotherapy : official j [Category] [DOI] 10.1016/j.jiac.2021.12.021 PMC 바로가기 [Article Type] Article
Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer세 번째 COVID-19 예방 접종 후 면역 반응은 고형암 환자에 비해 혈액 악성 종양 환자에서 감소합니다Comparative Study Published on 2022-02-142022-09-11 Journal: Cancer cell [Category] [DOI] 10.1016/j.ccell.2021.12.013 PMC 바로가기 [Article Type] Comparative Study